163 related articles for article (PubMed ID: 25598491)
1. Recurrent encephaloclastic cyst induced by intraventricular topotecan.
Mella DB; Kamiya-Matsuoka C; Liao B; Tummala S; de Groot J
J Neurol Sci; 2015 Feb; 349(1-2):52-3. PubMed ID: 25598491
[TBL] [Abstract][Full Text] [Related]
2. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Barba D
J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
[TBL] [Abstract][Full Text] [Related]
3. [Use of Ommaya reservoirs in the treatment of meningeal relapse of acute lymphoblastic leukemia].
Janvier M; Leverger G; Renier D; Poirier O; Tobelem G; Boiron M
Nouv Rev Fr Hematol (1978); 1984; 26(5):295-8. PubMed ID: 6594669
[TBL] [Abstract][Full Text] [Related]
4. Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies.
Kramer K; Smith M; Souweidane MM
Pediatr Blood Cancer; 2014 Sep; 61(9):1590-2. PubMed ID: 24777835
[TBL] [Abstract][Full Text] [Related]
5. Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.
Zairi F; Le Rhun E; Bertrand N; Boulanger T; Taillibert S; Aboukais R; Assaker R; Chamberlain MC
J Neurooncol; 2015 Sep; 124(2):317-23. PubMed ID: 26070555
[TBL] [Abstract][Full Text] [Related]
6. Chemoport with a non-collapsible chamber as a replacement for an Ommaya reservoir in the treatment of leptomeningeal carcinomatosis.
Gwak HS; Lee CH; Yang HS; Joo J; Shin SH; Yoo H; Lee JS; Lee SH
Acta Neurochir (Wien); 2011 Oct; 153(10):1971-8; discussion 1978. PubMed ID: 21796363
[TBL] [Abstract][Full Text] [Related]
7. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
Tran HC; Gardner S; Weiner HL; Liebes LF; Finlay JL
J Oncol Pharm Pract; 2014 Jun; 20(3):229-32. PubMed ID: 23929729
[TBL] [Abstract][Full Text] [Related]
8. Navigation-guided Ommaya reservoir placement: implications for the treatment of leptomeningeal metastases.
Takahashi M; Yamada R; Tabei Y; Nakamura O; Shinoura N
Minim Invasive Neurosurg; 2007 Dec; 50(6):340-5. PubMed ID: 18210356
[TBL] [Abstract][Full Text] [Related]
9. [Radioisotope ventriculography for functional evaluation of the Ommaya Reservoir (author's transl)].
Yamada K; Ushio Y; Hayakawa T; Mogami H; Bremer AM; West CR
No Shinkei Geka; 1980 Jan; 8(1):49-54. PubMed ID: 7360305
[TBL] [Abstract][Full Text] [Related]
10. Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma.
Shackleford GM; Mahdi MY; Moats RA; Hawes D; Tran HC; Finlay JL; Hoang TQ; Meng EF; Erdreich-Epstein A
PLoS One; 2019; 14(1):e0206394. PubMed ID: 30608927
[TBL] [Abstract][Full Text] [Related]
11. Ommaya reservoirs for the treatment of leptomeningeal metastases.
Sandberg DI; Bilsky MH; Souweidane MM; Bzdil J; Gutin PH
Neurosurgery; 2000 Jul; 47(1):49-54; discussion 54-5. PubMed ID: 10917346
[TBL] [Abstract][Full Text] [Related]
12. The Ommaya reservoir: newly recognized complications and recommendations for insertion and use.
Bleyer WA; Pizzo PA; Spence AM; Platt WD; Benjamin DR; Kolins CJ; Poplack DG
Cancer; 1978 Jun; 41(6):2431-7. PubMed ID: 274993
[TBL] [Abstract][Full Text] [Related]
13. The use of a smartphone-assisted ventricle catheter guide for Ommaya reservoir placement-experience of a retrospective bi-center study.
Ozerov S; Thomale UW; Schulz M; Schaumann A; Samarin A; Kumirova E
Childs Nerv Syst; 2018 May; 34(5):853-859. PubMed ID: 29322340
[TBL] [Abstract][Full Text] [Related]
14. Encephaloclastic cyst: a rare complication of a malfunctioning methotrexate Ommaya reservoir.
Lubomski M; Pell M; Lochhead A; Jude M
Intern Med J; 2018 Feb; 48(2):224-226. PubMed ID: 29415363
[No Abstract] [Full Text] [Related]
15. Methotrexate-induced encephaloclastic cyst: a complication of intraventricular chemotherapy.
Chowdhary S; Chalmers LM; Chamberlain PA
Neurology; 2006 Jul; 67(2):319. PubMed ID: 16864827
[No Abstract] [Full Text] [Related]
16. Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate.
Goto Y; Katsumata N; Nakai S; Sasajima Y; Yonemori K; Kouno T; Shimizu C; Ando M; Fujiwara Y
Int J Clin Oncol; 2008 Dec; 13(6):555-8. PubMed ID: 19093186
[TBL] [Abstract][Full Text] [Related]
17. Favorable response of intraommaya topotecan for leptomeningeal metastasis of neuroblastoma after intravenous route failure.
Sirachainan N; Visudtibhan A; Tuntiyatorn L; Pakakasama S; Chuansumrit A; Hongeng S
Pediatr Blood Cancer; 2008 Jan; 50(1):169-72. PubMed ID: 16572404
[TBL] [Abstract][Full Text] [Related]
18. Complications related to the placement of an intraventricular chemotherapy device.
Zairi F; Le Rhun E; Tetard MC; Kotecki N; Assaker R
J Neurooncol; 2011 Aug; 104(1):247-52. PubMed ID: 21107993
[TBL] [Abstract][Full Text] [Related]
19. Safety of Ommaya reservoirs in children with brain tumors: a 20-year experience with 5472 intraventricular drug administrations in 98 patients.
Peyrl A; Chocholous M; Azizi AA; Czech T; Dorfer C; Mitteregger D; Gojo J; Minichmayr E; Slavc I
J Neurooncol; 2014 Oct; 120(1):139-45. PubMed ID: 25017328
[TBL] [Abstract][Full Text] [Related]
20. Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
Jaeckle KA; Dixon JG; Anderson SK; Moreno-Aspitia A; Colon-Otero G; Hebenstreit K; Patel TA; Reddy SL; Perez EA
Cancer Med; 2020 Nov; 9(21):7935-7942. PubMed ID: 32885617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
